Selank is a synthetic nootropic peptide derived from tuftin, a natural protein of the immune system. Developed in Russia, it is primarily used for its anxiolytic (anti-anxiety) and cognitive-enhancing properties, without causing dependence or sedation like traditional benzodiazepines.

Main Benefits:

• Significant reduction of anxiety and stress without sedation.

• Improved mental clarity, focus, and concentration.

• Increased learning and memory capacity

• Modulation of neurotransmitters (GABA, serotonin, dopamine)

• Antidepressant effects and mood stabilization

• Increased emotional resilience and stress management

• Immunomodulatory and anti-inflammatory properties

• Elevated BDNF (brain-derived neurotrophic factor)

• Neuroprotection and support for neuroplasticity

• It does not cause dependence, tolerance, or withdrawal syndrome.

Typical Dosages:

- Anxiety: 0.2-0.5 mg per day (subcutaneous)

- Cognitive Enhancement: 0.1-0.2 mg per day (subcutaneous)

- Nasal Spray: 1-3 sprays per day (0.6-1 mg)

- Cycle Protocol: 4-6 weeks ON, 2-4 weeks OFF

- Administration: Preferably in the morning, on an empty stomach.

Selank works through allosteric modulation of GABA-A receptors, positively influencing the expression of genes involved in neurotransmission. Its anxiolytic effects are comparable to benzodiazepines, but without the characteristic side effects (amnesia, dependence). Benefits manifest within 1-2 weeks, with more robust cognitive effects appearing in 4-6 weeks. It is frequently combined with Semax for nootropic synergy (Selank for calm + Semax for focus).

Important Note: Selank is clinically approved in Russia but not FDA approved. It is considered an investigational peptide in the US and Europe. Requires appropriate medical supervision.